136 related articles for article (PubMed ID: 18977516)
1. A neoantigenic determinant in coiled coil region of human fibrin beta-chain.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Lugovskaya NE; Komisarenko SV
Thromb Res; 2009 Mar; 123(5):765-70. PubMed ID: 18977516
[TBL] [Abstract][Full Text] [Related]
2. Functional role of Bbeta-chain N-terminal fragment in the fibrin polymerization process.
Lugovskoy EV; Gritsenko PG; Kapustianenko LG; Kolesnikova IN; Chernishov VI; Komisarenko SV
FEBS J; 2007 Sep; 274(17):4540-9. PubMed ID: 17681017
[TBL] [Abstract][Full Text] [Related]
3. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
Raut S; Gaffney PJ
Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
[TBL] [Abstract][Full Text] [Related]
5. The study of fibrin polymerization with monoclonal antibodies.
Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
[TBL] [Abstract][Full Text] [Related]
6. A neoantigenic determinant in the D-dimer fragment of fibrin.
Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
[TBL] [Abstract][Full Text] [Related]
7. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
8. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
[TBL] [Abstract][Full Text] [Related]
9. Novel monoclonal antibody that recognizes new neoantigenic determinant of D-dimer.
Doh HJ; Song KS; Kang MS; Kim DS; Kim KA; Kang J; Jang Y; Chung KH
Thromb Res; 2006; 118(3):353-60. PubMed ID: 16139872
[TBL] [Abstract][Full Text] [Related]
10. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
[TBL] [Abstract][Full Text] [Related]
13. Screening for fibrin specific monoclonal antibodies: the development of a new procedure.
Tymkewycz PM; Creighton-Kempsford LJ; Hockley D; Gaffney PJ
Thromb Haemost; 1992 Jul; 68(1):48-53. PubMed ID: 1514172
[TBL] [Abstract][Full Text] [Related]
14. Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay.
Nagata S; Numata Y; Onda M; Ise T; Hahn Y; Lee B; Pastan I
J Immunol Methods; 2004 Sep; 292(1-2):141-55. PubMed ID: 15350519
[TBL] [Abstract][Full Text] [Related]
15. [Study of the polymerization of fibrin using monoclonal antibodies 2D-2A and their Fab-fragments].
Lugovskoĭ EV; Chudnovets VS; Makogonenko EM; Derzskaia SG; Gogolinskaia GK; Kolesnikova IN; Mikhalovskaia LI; Komissarenko SV
Ukr Biokhim Zh (1978); 1995; 67(1):64-70. PubMed ID: 8588256
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
[TBL] [Abstract][Full Text] [Related]
17. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
Cierniewski CS; Janiak A; Wyroba E
Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
[TBL] [Abstract][Full Text] [Related]
18. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
[TBL] [Abstract][Full Text] [Related]
19. [The role of complementary E2 and D2 centers in the reaction between fibrin and fibrinogen].
Ugarova TP; Kalikhevich VN; Ardemasova ZA; Belitser VA
Biokhimiia; 1987 Feb; 52(2):255-63. PubMed ID: 3567249
[TBL] [Abstract][Full Text] [Related]
20. Localization of an effective fibrin beta-chain polymerization site: implications for the polymerization mechanism.
Hsieh Kh
Biochemistry; 1997 Aug; 36(31):9381-7. PubMed ID: 9235981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
